Search results for

Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.

Tesla's profits were up from this time last year. But the company warned investors to prepare for expensive investments in next-generation technology like humanoid robots and AI.

"Where are the Black photographers?" Deborah Willis on how she turned that question into an artistic mission.

It's no secret that going to college can be very expensive, with tuition costs rising faster than financial aid. But what's causing that price tag to rise so quickly?

The Supreme Court hears arguments in a case about President Trump's firing of a Federal Trade Commissioner. At stake is a 90-year precedent limiting the president's power over independent agencies.

NPR's Steve Inskeep asks WNBA star Napheesa Collier about the league's new contract with the players and the state of women's sports.

Around 700,000 people are expected to attend Stonewall Columbus' Pride celebration Friday and Saturday, which will bring an expected $7.5 million to the region.

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

Early scandals have not slowed lawyers' adoption of AI tools, even as court sanctions over fake legal briefs continue to rise.

U.S. allies at the Group of Seven summit are pushing the war in Ukraine back on President Donald Trump's agenda. The Iran conflict has recently overshadowed the war in Ukraine.